Q1 2019 Ocular Therapeutix Inc Earnings Call Transcript
Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Ocular Therapeutix first quarter earnings conference call. (Operator Instructions)
It is now my pleasure to turn the call over to Donald Notman, Chief Financial Officer of Ocular Therapeutix. Please go ahead, sir.
Thank you, Liz. Good morning, everyone, and thank you for joining us on our first quarter 2019 financial results and business update conference call. This morning, we issued a press release providing an update on the company's product development programs and details of the company's financial results for the quarter ended March 31, 2019. The press release can be accessed on the Investors portion of our website at investors.ocutx.com.
Leading the call today will be Antony Mattessich, our President and Chief Executive Officer, who will provide an update on plans for the upcoming commercial launch DEXTENZA and a summary of our corporate developments and upcoming clinical milestones. Also speaking on the call
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |